Medivirs PowerPoint PPT Presentations

Medivir's late preclinical projects Bertil Samuelsson, VP Discovery Research ... Business model and R&D day summary Lars Adlersson, CEO Medivir AB ...

VTT Technical Research Centre of Finland. VTT TECHNICAL RESEARCH ... Epicrisis delivery (from patient info system) Laboratory results (from patient info system) ...

Cutaneous T-Cell Lymphoma is a group of lympho -proliferative disorders characterized by localization of neoplastic T lymphocytes to the skin. Collectively, CTCL is classified as a type of non-Hodgkin lymphoma (NHL).

Cold sore also known as herpes labialis is a viral infection cause by herpes simplex virus. It is characterized by red, fluid-filled blisters or ulcers that appear on the lips and around the mouth. These blisters are often appearing as patches, when it breaks a crust forms over the resulting sore.

Title: CURRENT CHALLENGES IN THE DIAGNOSIS/MANAGEMENT OF OSTEOPOROSIS IN THE UK Author: John Stevenson Last modified by: John Created Date: 3/21/2000 2:05:26 PM

Actualizaci n de Nuevas Terapias de la Hepatitis C. Dr Ricard Sol ... Adapted from: ... IRES. Polimerasa. Proteasa. P7. Receptor entrada. Helicasa ...

Hepatitis Liver transplantation ... 1) Tzakis AG et al., Transplantation 1990;49:354-358 ... Impact of HIV on survival after liver transplantation in the HAART era ...

Dept of Infectious Diseases/HIV Medicine, Royal Free Hospital ... Boceprevir (Schering-Plough) TMC435350 (Tibotec & Medivir) Nucleoside polymerase inhibitor ...

Hepatitis C Infection: Challenges and Evolving Opportunities

The pharmaceutical industry faces an unprecedented crisis of confidence from ... Set up to market primary care-oriented chronic care ... Cialis ...

Pharmaceutical out-sourcing to highly specialized biotechs ... FIPCO Fully integrated pharmaceutical company ... business model 'extremophile' companies ...

Reuse or distribution of any sort is prohibited without prior written permission ... Now Lilly/Icos' Cialis though actual compound was a Glaxo lead (while GSK ...

AstraZeneca, Pfizer, Biovitrum, KaroBio, Active Biotech, Medivir ... Acquired Pfizer's Healon activities in 2004. Invests in Sweden: ...

Partnership with Tibotec / Johnson & Johnson since November 2004. Phase Ia/b completed ... Paraesthesia. Photosensitivity. 11. TMC435350 Phase Ib Completed ...

Request for scientific information - less need for extensive promotional budgets ... Step-wise approach. Partnering. In-licensing / acquisitions. Own products ...

Cathepsin K Inhibitors for the Treatment of Bone Metastasis E. Lindstr m1, L. Vrang1, S. Sedig1, Y. Terelius1, B.-L. Sahlberg1, K. Wikstr m1, B. Samuelsson1, T.J ...

Investment will leverage technology to new inflection point. Competitive advantage ... From Small Biotech to large Pharmaceutical. Size (Contracts from 25,000 ...